| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Nov 15, 2024 | Tax Payment (Shares) | $6.18 | 11,937 | 73,711 | 1,487,694 | Nov 19, 2024, 06:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Nov 13, 2024 | Sale | $7.66 | 15,000 | 114,876 | 1,499,631 | Nov 14, 2024, 07:19 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Nov 12, 2024 | Option/RSU Exercise | $2.22 | 39,375 | 87,413 | 1,490,256 | Nov 14, 2024, 07:19 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Nov 12, 2024 | Sale | $7.64 | 15,000 | 114,629 | 1,475,256 | Nov 14, 2024, 07:19 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Nov 13, 2024 | Option/RSU Exercise | $2.22 | 39,375 | 87,413 | 1,514,631 | Nov 14, 2024, 07:19 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Oct 08, 2024 | Sale | $6.32 | 15,000 | 94,757 | 1,426,506 | Oct 10, 2024, 06:40 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Oct 09, 2024 | Option/RSU Exercise | $2.22 | 39,375 | 87,413 | 1,465,881 | Oct 10, 2024, 06:40 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Oct 09, 2024 | Sale | $6.36 | 15,000 | 95,375 | 1,450,881 | Oct 10, 2024, 06:40 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Oct 08, 2024 | Option/RSU Exercise | $2.22 | 39,375 | 87,413 | 1,441,506 | Oct 10, 2024, 06:40 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Sep 10, 2024 | Option/RSU Exercise | $2.22 | 39,375 | 87,413 | 1,392,756 | Sep 12, 2024, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Sep 10, 2024 | Sale | $6.17 | 15,000 | 92,499 | 1,377,756 | Sep 12, 2024, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Sep 11, 2024 | Option/RSU Exercise | $2.22 | 39,375 | 87,413 | 1,417,131 | Sep 12, 2024, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Sep 11, 2024 | Sale | $6.32 | 15,000 | 94,729 | 1,402,131 | Sep 12, 2024, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Aug 15, 2024 | Tax Payment (Shares) | $6.69 | 11,962 | 80,026 | 1,353,381 | Aug 19, 2024, 07:09 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Aug 13, 2024 | Option/RSU Exercise | $2.22 | 39,375 | 87,413 | 1,355,968 | Aug 15, 2024, 05:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Aug 13, 2024 | Sale | $6.35 | 15,000 | 95,182 | 1,340,968 | Aug 15, 2024, 05:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Aug 14, 2024 | Option/RSU Exercise | $2.22 | 39,375 | 87,413 | 1,380,343 | Aug 15, 2024, 05:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Aug 14, 2024 | Sale | $6.35 | 15,000 | 95,252 | 1,365,343 | Aug 15, 2024, 05:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jul 09, 2024 | Option/RSU Exercise | $2.22 | 39,375 | 87,413 | 1,307,218 | Jul 11, 2024, 04:51 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jul 09, 2024 | Sale | $7.32 | 15,000 | 109,778 | 1,292,218 | Jul 11, 2024, 04:51 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jul 10, 2024 | Option/RSU Exercise | $2.22 | 39,375 | 87,413 | 1,331,593 | Jul 11, 2024, 04:51 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jul 10, 2024 | Sale | $7.24 | 15,000 | 108,576 | 1,316,593 | Jul 11, 2024, 04:51 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jun 14, 2024 | Option/RSU Exercise | $2.22 | 39,375 | 87,413 | 1,282,843 | Jun 17, 2024, 05:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jun 14, 2024 | Sale | $9.27 | 15,000 | 139,082 | 1,267,843 | Jun 17, 2024, 05:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jun 13, 2024 | Option/RSU Exercise | $2.22 | 39,375 | 87,413 | 1,258,468 | Jun 17, 2024, 05:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jun 13, 2024 | Sale | $9.32 | 15,000 | 139,798 | 1,243,468 | Jun 17, 2024, 05:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | May 15, 2024 | Tax Payment (Shares) | $10.01 | 11,962 | 119,740 | 1,219,093 | May 17, 2024, 07:11 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Apr 17, 2024 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 1,254,179 | Apr 18, 2024, 05:12 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Apr 17, 2024 | Sale | $7.58 | 23,124 | 175,349 | 1,231,055 | Apr 18, 2024, 05:12 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Apr 16, 2024 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 1,241,679 | Apr 18, 2024, 05:12 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Apr 16, 2024 | Sale | $7.67 | 25,000 | 191,657 | 1,216,679 | Apr 18, 2024, 05:12 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Mar 12, 2024 | Sale | $10.45 | 25,000 | 261,375 | 1,191,679 | Mar 14, 2024, 07:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Mar 13, 2024 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 1,229,179 | Mar 14, 2024, 07:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Mar 13, 2024 | Sale | $11.03 | 25,000 | 275,815 | 1,204,179 | Mar 14, 2024, 07:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Mar 12, 2024 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 1,216,679 | Mar 14, 2024, 07:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Feb 15, 2024 | Tax Payment (Shares) | $12.43 | 7,172 | 89,148 | 1,179,179 | Feb 16, 2024, 07:59 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Feb 13, 2024 | Sale | $9.86 | 25,000 | 246,560 | 1,173,851 | Feb 15, 2024, 06:00 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Feb 14, 2024 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 1,211,351 | Feb 15, 2024, 06:00 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Feb 14, 2024 | Sale | $10.46 | 25,000 | 261,425 | 1,187,418 | Feb 15, 2024, 06:00 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Feb 13, 2024 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 1,198,851 | Feb 15, 2024, 06:00 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Feb 09, 2024 | Tax Payment (Shares) | $10.09 | 2,512 | 25,346 | 1,161,351 | Feb 13, 2024, 07:01 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jan 16, 2024 | Sale | $10.45 | 25,000 | 261,160 | 968,514 | Jan 18, 2024, 06:37 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jan 17, 2024 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 1,006,014 | Jan 18, 2024, 06:37 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jan 17, 2024 | Sale | $10.25 | 25,000 | 256,347 | 981,014 | Jan 18, 2024, 06:37 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jan 16, 2024 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 993,514 | Jan 18, 2024, 06:37 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Dec 12, 2023 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 968,514 | Dec 14, 2023, 06:53 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Dec 12, 2023 | Sale | $7.39 | 25,000 | 184,868 | 943,514 | Dec 14, 2023, 06:53 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Dec 13, 2023 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 981,014 | Dec 14, 2023, 06:53 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Dec 13, 2023 | Sale | $7.59 | 25,000 | 189,770 | 956,014 | Dec 14, 2023, 06:53 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Nov 15, 2023 | Sale | $7.32 | 25,000 | 182,986 | 942,886 | Nov 16, 2023, 06:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Nov 14, 2023 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 950,686 | Nov 16, 2023, 06:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Nov 14, 2023 | Sale | $6.32 | 25,000 | 157,942 | 925,686 | Nov 16, 2023, 06:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Nov 15, 2023 | Tax Payment (Shares) | $7.18 | 7,172 | 51,495 | 931,014 | Nov 16, 2023, 06:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Nov 15, 2023 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 963,186 | Nov 16, 2023, 06:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Oct 11, 2023 | Sale | $6.85 | 25,000 | 171,312 | 913,186 | Oct 12, 2023, 06:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Oct 10, 2023 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 925,686 | Oct 12, 2023, 06:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Oct 10, 2023 | Sale | $7.07 | 25,000 | 176,762 | 900,686 | Oct 12, 2023, 06:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Oct 11, 2023 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 938,186 | Oct 12, 2023, 06:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Sep 13, 2023 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 913,186 | Sep 14, 2023, 06:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Sep 13, 2023 | Sale | $8.69 | 25,000 | 217,318 | 888,186 | Sep 14, 2023, 06:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Sep 12, 2023 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 900,686 | Sep 14, 2023, 06:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Sep 12, 2023 | Sale | $8.43 | 25,000 | 210,632 | 875,686 | Sep 14, 2023, 06:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Aug 15, 2023 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 875,686 | Aug 17, 2023, 06:35 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Aug 15, 2023 | Sale | $9.27 | 25,000 | 231,792 | 850,686 | Aug 17, 2023, 06:35 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Aug 16, 2023 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 888,186 | Aug 17, 2023, 06:35 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Aug 16, 2023 | Sale | $8.90 | 25,000 | 222,517 | 863,186 | Aug 17, 2023, 06:35 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Aug 15, 2023 | Tax Payment (Shares) | $9.19 | 4,727 | 43,441 | 838,186 | Aug 17, 2023, 06:35 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jul 18, 2023 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 855,413 | Jul 19, 2023, 07:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jul 18, 2023 | Sale | $13.63 | 25,000 | 340,802 | 830,913 | Jul 19, 2023, 07:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jul 19, 2023 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 867,913 | Jul 19, 2023, 07:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jul 19, 2023 | Sale | $15.53 | 25,000 | 388,348 | 865,922 | Jul 19, 2023, 07:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jun 13, 2023 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 830,413 | Jun 15, 2023, 07:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jun 13, 2023 | Sale | $9.93 | 25,000 | 248,307 | 805,413 | Jun 15, 2023, 07:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jun 14, 2023 | Option/RSU Exercise | $2.22 | 37,500 | 83,250 | 842,913 | Jun 15, 2023, 07:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Jun 14, 2023 | Sale | $10.07 | 25,000 | 251,837 | 817,913 | Jun 15, 2023, 07:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | May 15, 2023 | Tax Payment (Shares) | $5.60 | 4,760 | 26,656 | 790,159 | May 17, 2023, 06:17 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Feb 04, 2022 | Tax Payment (Shares) | $11.40 | 678 | 7,729 | 590,380 | Apr 28, 2023, 04:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Feb 15, 2023 | Tax Payment (Shares) | $8.44 | 1,258 | 10,618 | 794,310 | Feb 17, 2023, 05:15 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Feb 01, 2023 | Tax Payment (Shares) | $8.55 | 2,669 | 22,820 | 795,568 | Feb 03, 2023, 05:14 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Nov 15, 2022 | Tax Payment (Shares) | $11.86 | 1,065 | 12,631 | 586,572 | Nov 17, 2022, 06:45 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Aug 15, 2022 | Tax Payment (Shares) | $12.96 | 1,065 | 13,802 | 587,637 | Aug 17, 2022, 06:33 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | May 16, 2022 | Tax Payment (Shares) | $5.67 | 1,069 | 6,061 | 588,702 | May 18, 2022, 07:17 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Feb 04, 2022 | Tax Payment (Shares) | $11.40 | 678 | 7,729 | 589,771 | Feb 08, 2022, 09:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Michael Secora | Chief Financial Officer | Apr 20, 2021 | Conversion | - | 149,077 | - | 528,762 | Apr 22, 2021, 08:09 PM |
